Cvill6 and Cvill7: Potent and Selective Peptide Blockers of Kv1.2 Ion Channel Isolated from Mexican Scorpion Centruroides villegasi
Toxins · 2025
DOI: 10.3390/toxins17060279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxins, 2025. Verfasst von Kashmala Shakeel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics and Cell Biology, Faculty of Medicine, Research Center for Molecular Medicine, University of Debrecen, Egyetem ter. 1, 4032 …. Hauptthemen laut MEDLINE: Scorpion Venoms, Kv1.2 Potassium Channel, Potassium Channel Blockers, Scorpions. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Fund, Hungarian National Research, Development, and Innovation Office, National Council of Science and Technology of Mexico.
Abstract (Originalsprache)
Scorpion venoms are a rich source of peptides that modulate the activity of ion channels and can serve as a new drug for channelopathies. Cvill6 and Cvill7 are two new peptides isolated from the venom of Centruroides villegasi with MW of 4277 Da and 4287 Da and they consist of 38 and 39 amino acids, respectively, including six cysteines. Sequence alignment revealed high similarity with members of the α-KTx2 subfamily of potassium channel toxins. In electrophysiology, Cvill7 potently inhibited Kv1.2 ion channels with an IC50 of 16 pM and Kv1.3 with an IC50 of 7.2 nM. In addition, it exhibited partial activity on KCa3.1 and Kv1.1, with ~16% and ~34% inhibition at 100 nM, respectively. In contrast, Cvill6 blocked Kv1.2 with low affinity (IC50 of 3.9 nM) and showed modest inhibition of Kv1.3 (~11%) and KCa3.1 (~27%) at 100 nM concentration. Neither peptide showed any activity against other K+ channels tested in this study (Kv1.5, Kv11.1, KCa1.1, and KCa2.2). Notably, Cvill7 has a remarkable affinity for Kv1.2 and high selectivity of 450-fold over Kv1.3 and 12,000-fold over Kv1.1. These pharmacological properties make Cvill7 a potential candidate to target Kv1.2 gain of function (GOF)-related channelopathies such as epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biophysics and Cell Biology, Faculty of Medicine, Research Center for Molecular Medicine, University of Debrecen, Egyetem ter. 1, 4032 Debrecen, Hungary.
- Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnologia, Universidad Nacional Autónoma de México, Av. Universidad 2001, Cuernavaca 62210, Mexico.
ORCID-Profile: Kashmala Shakeel, Muhammad Umair Naseem, Lourival Domingos Possani, Gyorgy Panyi
Förderung
- Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Fund
- Hungarian National Research, Development, and Innovation Office
- National Council of Science and Technology of Mexico
Zitieren
APA
Shakeel, K., Naseem, M. U., Olamendi-Portugal, T., Zamudio, F. Z., Possani, L. D., & Panyi, G. (2025). Cvill6 and Cvill7: Potent and Selective Peptide Blockers of Kv1.2 Ion Channel Isolated from Mexican Scorpion Centruroides villegasi. Toxins. https://doi.org/10.3390/toxins17060279
Vancouver
Shakeel K, Naseem MU, Olamendi-Portugal T, Zamudio FZ, Possani LD, Panyi G. Cvill6 and Cvill7: Potent and Selective Peptide Blockers of Kv1.2 Ion Channel Isolated from Mexican Scorpion Centruroides villegasi. Toxins. 2025. doi:10.3390/toxins17060279
BibTeX
@article{Shakeel2025,
author = {Shakeel, Kashmala and Naseem, Muhammad Umair and Olamendi-Portugal, Timoteo and Zamudio, Fernando Z and Possani, Lourival Domingos and Panyi, Gyorgy},
title = {Cvill6 and Cvill7: Potent and Selective Peptide Blockers of Kv1.2 Ion Channel Isolated from Mexican Scorpion Centruroides villegasi},
journal = {Toxins},
year = {2025},
doi = {10.3390/toxins17060279}
}
EUVIMED